Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

12.82
Delayed Data
As of May 01
 +0.02 / +0.16%
Today’s Change
7.09
Today|||52-Week Range
14.07
+54.46%
Year-to-Date

Today’s Trading

Previous close12.80
Today’s open12.90
Day’s range12.52 - 13.16
Volume685,457
Average volume (3 months)603,253
Market cap$599.7M
Dividend yield--
Data as of 05/01/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-62.50%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio32.6
Price/Sales2.87
Price/Book7.72

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.40+1.96%
XNCRXencor Inc+0.39+2.74%
VTLVital Therapies Inc+0.17+0.70%
FLMLFlamel Technologies ...+0.46+3.31%
Data as of 05/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers